Neurology

Spasticity in MND Improved With Cannabinoid Oral Spray




Nabiximols, a cannabinoid-based oral spray approved outside the US for MS symptoms, shows improvement of spasticity in amyotrophic and primary lateral sclerosis when used as add-on therapy.
Medscape Medical News

Source link




Related posts

Congresswoman Louise M. Slaughter (1929-2018)

Newsemia

Zebra sign specific to ALS or not

Newsemia

Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy